Focus
Drug Discovery Investors: Angels and VC Firms
The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.
Strongest in New York, San Francisco and Boston
- 4,683
- Drug Discovery investors
- 239
- Angel investors
- 4,444
- People at VC/PE firms
- 1,313
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
4,683 Drug Discovery investors
Showing 61-80
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
 Peter Kolchinsky Managing Partner at RA Capital Management | Boston, United States | Private equityVenture capital | FinTechHealthcare | View profile | |
 Larry Lasky Investor at The Column Group | Sausalito, United States | Venture capital | Healthcare | View profile | |
 Bernard-Louis Roques Co-Founder & CEO at Truffle Capital | Paris, France | Private equitySyndicate / Angel group | ClimateConsumer | View profile | |
 Bharat Srinivasa Founder. Investor. Partner at Amplitude Ventures | Toronto, Canada | Venture capital | AIHealthcare | View profile | |
 Rainer Strohmenger Managing Partner at Wellington Partners | Munich, Germany | Venture capital | AICommerce | View profile | |
 Kaasim Mahmood General Partner at Advent Life Sciences | London, United Kingdom | Venture capital | Healthcare | View profile | |
 Dandan Dong Venture Partner at TCGX | Palo Alto, United States | Private equity | Healthcare | View profile | |
 Karl Rothweiler Managing Partner at Aglaia Oncology Funds | De Bilt, Netherlands | Venture capital | Healthcare | View profile | |
 Phil Ferneau Investor at Adimab | Hanover, United States | Corporate VCVenture capital | AIClimate | View profile | |
 Victor Stone General Partner at 82VS | Cambridge, United States | AcceleratorCorporate VC | AIHealthcare | View profile | |
 Eileen McGuire Investor at Polaris Partners | Boston, United States | Venture capital | AIHealthcare | View profile | |
 Shahzad Malik General Partner at Advent Life Sciences | London, United Kingdom | Venture capital | Healthcare | View profile | |
 Aimee Raleigh Principal at Atlas Venture | Boston, United States | Venture capital | CommerceConsumer | View profile | |
 Ryan Wooten Managing Director at NovaQuest Capital Management | Raleigh, United States | Private equityVenture debt | Healthcare | View profile | |
 Mark Krul Founder and Director at Aglaia Oncology Funds | Netherlands | Venture capital | Healthcare | View profile | |
 David Pakman Venture Partner at CoinFund | New York, United States | Private equityVenture capital | AICommerce | View profile | |
 Dave Barrett Managing Partner at Polaris Partners | Boston, United States | Venture capital | AIHealthcare | View profile | |
 Troy Osinoff General Partner at MAGIC Fund | New York, United States | Venture capital | AICommerce | View profile | |
 Paul Dossa Investor at Venrock | New York City, United States | Private equityVenture capital | AICommerce | View profile | |
 Robert Hester Partner and Chief Financial Officer at NovaQuest Capital Management | Raleigh, United States | Private equityVenture debt | Healthcare | View profile |
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal